An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2015, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2015-06-11
DOI
10.1155/2015/803971
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice
- (2014) Xia Cao et al. HYPERTENSION RESEARCH
- In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery
- (2014) S. Jose et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Resveratrol attenuates hypoxia/reoxygenation-induced Ca2+ overload by inhibiting the Wnt5a/Frizzled-2 pathway in rat H9c2 cells
- (2014) XIANG WU et al. Molecular Medicine Reports
- Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
- (2014) Renzo Mancuso et al. Neurotherapeutics
- Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo
- (2014) Sang Hyuk Hong et al. Pharmacological Reports
- Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1G93AMouse Model of Amyotrophic Lateral Sclerosis
- (2014) Lin Song et al. Biomed Research International
- High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men
- (2013) Satya Dash et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression
- (2013) P. Liu et al. Clinical & Translational Oncology
- Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
- (2013) Joao Tomé-Carneiro et al. CURRENT PHARMACEUTICAL DESIGN
- Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: Possible role of SOCS-1 in reducing pro-inflammatory responses
- (2013) Dario D Lofrumento et al. Innate Immunity
- Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells
- (2013) HONGMEI LUO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF-β/Smad3 Pathway
- (2013) Xin-Zhong Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Resveratrol Protects DAergic PC12 Cells from High Glucose-Induced Oxidative Stress and Apoptosis: Effect on p53 and GRP75 Localization
- (2013) Justine Renaud et al. NEUROTOXICITY RESEARCH
- Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4′-tri-O-acetylresveratrol in rats
- (2013) Li Liang et al. PHYTOMEDICINE
- Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction
- (2013) Jin Liang et al. RENAL FAILURE
- Resveratrol Reverses Remodeling in Hearts with Large, Old Myocardial Infarctions through Enhanced Autophagy-Activating AMP Kinase Pathway
- (2012) Hiromitsu Kanamori et al. AMERICAN JOURNAL OF PATHOLOGY
- A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
- (2012) Rakesh Popat et al. BRITISH JOURNAL OF HAEMATOLOGY
- Resveratrol Helps Recovery from Fatty Liver and Protects against Hepatocellular Carcinoma Induced by Hepatitis B Virus X Protein in a Mouse Model
- (2012) H.-C. Lin et al. Cancer Prevention Research
- Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance
- (2012) Jun Yoshino et al. Cell Metabolism
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
- (2012) Nathan L. Price et al. Cell Metabolism
- Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
- (2012) A. R. Neves et al. CURRENT MEDICINAL CHEMISTRY
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- Resveratrol promotes neurotrophic factor release from astroglia
- (2012) Feng Zhang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
- (2012) Jill P. Crandall et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats
- (2012) Lina Wu et al. MOLECULAR BIOLOGY REPORTS
- Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
- (2012) Jayesh Kumar Bhatt et al. NUTRITION RESEARCH
- Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2–Keap1 signaling
- (2011) P. Palsamy et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
- (2011) S. Gómez-Zorita et al. BRITISH JOURNAL OF NUTRITION
- Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
- (2011) Pál Brasnyó et al. BRITISH JOURNAL OF NUTRITION
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
- (2011) Silvie Timmers et al. Cell Metabolism
- Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats
- (2011) Siddhartha R. Bhatt et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Characterization of trans-Resveratrol-Loaded Lipid-Core Nanocapsules and Tissue Distribution Studies in Rats
- (2011) Rudimar L. Frozza et al. Journal of Biomedical Nanotechnology
- Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade
- (2011) Hemachander Capiralla et al. JOURNAL OF NEUROCHEMISTRY
- Analytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies
- (2011) Otito F. Iwuchukwu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats
- (2011) Yanchun Wang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Challenges of Translating Basic Research Into Therapeutics: Resveratrol as an Example
- (2011) J. M. Smoliga et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Enhancing the bioavailability of resveratrol by combining it with piperine
- (2011) Jeremy J. Johnson et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors
- (2011) Sanjit K. Roy et al. PLoS One
- Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure
- (2011) Stéphanie Rimbaud et al. PLoS One
- Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK
- (2010) Da-Fa Ding et al. AMERICAN JOURNAL OF NEPHROLOGY
- Anticancer Activity and Molecular Mechanism of Resveratrol–Bovine Serum Albumin Nanoparticles on Subcutaneously Implanted Human Primary Ovarian Carcinoma Cells in Nude Mice
- (2010) Liyuan Guo et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
- (2010) Izet M. Kapetanovic et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Resveratrol Suppresses Oxidative Stress and Inflammatory Response in Diethylnitrosamine-Initiated Rat Hepatocarcinogenesis
- (2010) A. Bishayee et al. Cancer Prevention Research
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
- (2010) H.-H. S. Chow et al. Cancer Prevention Research
- Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase
- (2010) N. Oi et al. CANCER RESEARCH
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
- (2010) V. A. Brown et al. CANCER RESEARCH
- Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects
- (2010) Charles la Porte et al. CLINICAL PHARMACOKINETICS
- Resveratrol Improves Insulin Resistance Hyperglycemia and Hepatosteatosis But Not Hypertriglyceridemia, Inflammation, and Life Span in a Mouse Model for Werner Syndrome
- (2010) Adam Labbé et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer
- (2010) Randall F Holcombe et al. Cancer Management and Research
- Protective Effects of Resveratrol and Quercetin Against MPP+ -Induced Oxidative Stress Act by Modulating Markers of Apoptotic Death in Dopaminergic Neurons
- (2009) Julie Bournival et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
- (2009) Vernon W. Dolinsky et al. CIRCULATION
- AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
- (2009) J.-H. Um et al. DIABETES
- Pharmacokinetics ofTrans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
- (2009) Teresa Nunes et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Resveratrol bioavailability and toxicity in humans
- (2009) Charles-Henry Cottart et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice
- (2008) Gyeong-Min Do et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity
- (2008) Yu-Min Yang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
- (2008) Jiyun Ahn et al. JOURNAL OF HEPATOLOGY
- The Impact of Aqueous Solubility and Dose on the Pharmacokinetic Profiles of Resveratrol
- (2008) Surajit Das et al. PHARMACEUTICAL RESEARCH
- Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis
- (2007) Neetu Kalra et al. LIFE SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now